Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP381638.RAsWvAAkpCtXtD88ueOcZL_1NRCJ04B370T4q5SIr_VLA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP381638.RAsWvAAkpCtXtD88ueOcZL_1NRCJ04B370T4q5SIr_VLA130_assertion type Assertion NP381638.RAsWvAAkpCtXtD88ueOcZL_1NRCJ04B370T4q5SIr_VLA130_head.
- NP381638.RAsWvAAkpCtXtD88ueOcZL_1NRCJ04B370T4q5SIr_VLA130_assertion description "[Additionally, the presence of ERCC1 >3.0 or TS1 >6.0 was associated with an approximately 2-fold increase in the risk of cancer recurrence (P = 0.086 and 0.003, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381638.RAsWvAAkpCtXtD88ueOcZL_1NRCJ04B370T4q5SIr_VLA130_provenance.
- NP381638.RAsWvAAkpCtXtD88ueOcZL_1NRCJ04B370T4q5SIr_VLA130_assertion evidence source_evidence_literature NP381638.RAsWvAAkpCtXtD88ueOcZL_1NRCJ04B370T4q5SIr_VLA130_provenance.
- NP381638.RAsWvAAkpCtXtD88ueOcZL_1NRCJ04B370T4q5SIr_VLA130_assertion SIO_000772 15788669 NP381638.RAsWvAAkpCtXtD88ueOcZL_1NRCJ04B370T4q5SIr_VLA130_provenance.
- NP381638.RAsWvAAkpCtXtD88ueOcZL_1NRCJ04B370T4q5SIr_VLA130_assertion wasDerivedFrom befree-20150227 NP381638.RAsWvAAkpCtXtD88ueOcZL_1NRCJ04B370T4q5SIr_VLA130_provenance.
- NP381638.RAsWvAAkpCtXtD88ueOcZL_1NRCJ04B370T4q5SIr_VLA130_assertion wasGeneratedBy ECO_0000203 NP381638.RAsWvAAkpCtXtD88ueOcZL_1NRCJ04B370T4q5SIr_VLA130_provenance.